Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes
Lester, P.A.; Traynor, J.R.
Brain Research 1073-1074: 290-296
2006
ISSN/ISBN: 0006-8993
PMID: 16443205
DOI: 10.1016/j.brainres.2005.12.066
Accession: 011886500
Morphine and related opioid agonists are frequently used in dogs for their analgesic properties, their sedative effects and as adjuncts to anesthesia. Such compounds may be effective through a combined action at mu-, delta- and kappa-opioid receptors.
PDF emailed within 0-6 h: $19.90
Related References
Pfaus, J.G.; Pfaff, D.W. 1991: Selective mu opioid receptor agonists inhibit whereas delta and kappa receptor agonists facilitate lordosis behavior in the female rat differential modulation by progesterone Society for Neuroscience Abstracts 17(1-2): 498Park, Y.; Ma, T.; Tanaka, S.; Jang, C.; Loh, H.H.; Ko, K.H.; Ho, I.K. 2000: Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice Brain Research Bulletin 52(4): 297-302
Schiller, P.W.; Weltrowska, G.; Nguyen, T.M.-D.; Lemieux, C.; Chung, N.N.; Lu, Y. 2003: Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists Life Sciences 73(6): 691-698
Morgan, E.L. 1996: Regulation of human B lymphocyte activation by opioid peptide hormones. Inhibition of IgG production by opioid receptor class (mu-, kappa-, and delta-) selective agonists Journal of Neuroimmunology 65(1): 21-30
Baamonde, A.; Lastra, A.; Juárez, Lía.; García, Vónica.; Hidalgo, Aín.; Menéndez, L. 2005: Effects of the local administration of selective mu-, delta-and kappa-opioid receptor agonists on osteosarcoma-induced hyperalgesia Naunyn-Schmiedeberg's Archives of Pharmacology 372(3): 213-219
Leung, C.G.; Weinger, M.B.; Wieslander, C.; Wood, D.; Davidson, L.; Brisbane, C.; Tanguilig, C.; Ghausi, S.; Schulteis, G. 1998: ICV administration of selective delta and kappa opioid receptor agonists produce antinociception with limited side effects in the rat Society for Neuroscience Abstracts 24(1-2): 890
Oiso, Y.; Kondo, K.; Ito, M.; Iwasaki, Y.; Otake, K. 1990: Comparison of suppressive effects of opioid kappa receptor mu receptor and delta receptor agonists on arginine vasopressin secretion Neuroendocrinology Letters 12(6): 443-448
Asensio, Víctor.J.; Miralles, A.; García-Sevilla, Jús.A. 2006: Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal European Journal of Pharmacology 539(1-2): 49-56
Kamei, J.; Ohhashi, Y.; Aoki, T.; Kawasima, N.; Kasuya, Y. 1992: Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists Brain Research 571(2): 199-203
Oiso, Y.; Kondo, K.; Ito, M.; Iwasaki, Y.; Otake, K. 1990: Comparison of suppressive effects of opioid kappa-, mu- and delta-receptor agonists on arginine vasopressin secretion Neuro Endocrinology Letters 12(6): 443-448
Tseng, L.F.; Collins, K.A.; Kampine, J.P. 1994: Antisense oligodeoxynucleotide to a delta-opioid receptor selectively blocks the spinal antinociception induced by delta-, but not mu- or kappa-opioid receptor agonists in the mouse European Journal of Pharmacology 258(1-2): R1-R3
Narita, M.; Narita, M.; Bosnjak, Z.J.; Kampine, J.P.; Tseng, L.F. 1995: The antisense oligo to delta-opioid receptor mRNA prevents the recovery from acute antinociceptive tolerance to delta-, but not mu- or kappa-opioid receptor agonists in the mouse Society for Neuroscience Abstracts 21(1-3): 724
Wang, H.Q.; Kampine, J.P.; Tseng, L.F. 1996: Antisense oligodeoxynucleotide to a delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon- or kappa-opioid receptor agonists in the mouse Neuroscience 75(2): 445-452
Smith, C.B.; Medzihradsky, F.; Klick, K.A.; Clark, M.J. 1988: Different opioid receptor selectivity of delta agonists in the mouse vas deferens and rat brain membranes FASEB Journal 2(4): Abstract 393
Eckert, W.A.I.i; Mcnaughton, K.K.; Light, A.R. 1997: Membrane responses of rat spinal laminae I and II neurons recorded in vitro evoked by mu, kappa and delta opioid receptor agonists Society for Neuroscience Abstracts 23(1-2): 678
Rottmann, M.; Fábián, G.; Spicher, K.; Offermanns, S.; Szücs, M. 1998: Receptor-mediated activation of G-proteins by kappa opioid agonists in frog (Rana esculenta) brain membranes Brain Research Bulletin 45(5): 467-474
Xin, L.; Geller, E.B.; Adler, M.W. 1997: Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain Journal of Pharmacology and Experimental Therapeutics 281(1): 499-507
Ito, S.; Mori, T.; Sawaguchi, T. 2006: Differential effects of micro-opioid, delta-opioid and kappa-opioid receptor agonists on dopamine receptor agonist-induced climbing behavior in mice Behavioural Pharmacology 17(8): 691-701
Benoliel, J.J.; Bourgoin, S.; Mauborgne, A.; Legrand, J.C.; Hamon, M.; Cesselin, F. 1991: Differential inhibitory/stimulatory modulation of spinal CCK release by mu and delta opioid agonists, and selective blockade of mu-dependent inhibition by kappa receptor stimulation Neuroscience Letters 124(2): 204-207
Yang, L.; Islam, M.R.; Karamyan, V.T.; Abbruscato, T.J. 2015: In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment Brain Research 1609: 1-11